Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Daiichi Sankyo
Citi
Chinese Patent Office
Federal Trade Commission
Express Scripts
Dow
Farmers Insurance
Covington
Deloitte

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,920,377

« Back to Dashboard

Which drugs does patent 8,920,377 protect, and when does it expire?

Patent 8,920,377 protects AUVI-Q and is included in one NDA.

This patent has one hundred patent family members in fourteen countries.
Summary for Patent: 8,920,377
Title:Devices, systems and methods for medicament delivery
Abstract: An apparatus includes a housing, a medicament container, an actuator, and a biasing member. The actuator is configured to move the medicament container within the housing when the actuator is moved from a first configuration to a second configuration. The actuator includes a gas container and a puncturer. When the actuator is in the first configuration, a portion of the puncturer is disposed apart from the gas container. When the actuator is in the second configuration, the portion of the puncturer is disposed within the gas container. The gas container has a longitudinal axis offset from a longitudinal axis of the medicament container. The biasing member is configured to bias the actuator toward the second configuration.
Inventor(s): Edwards; Eric S. (Moseley, VA), Edwards; Evan T. (Charlottesville, VA)
Assignee: kaleo, Inc. (Richmond, VA)
Application Number:13/866,296
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Device;

Drugs Protected by US Patent 8,920,377

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Kaleo Inc AUVI-Q epinephrine INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 201739-002 Aug 10, 2012 BX RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Kaleo Inc AUVI-Q epinephrine INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 201739-001 Aug 10, 2012 BX RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,920,377

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,805,620 Medical injector simulation device ➤ Subscribe
9,278,182 Devices, systems and methods for medicament delivery ➤ Subscribe
8,608,698 Devices, systems and methods for medicament delivery ➤ Subscribe
8,123,719 Devices, systems and methods for medicament delivery ➤ Subscribe
8,231,573 Medicament delivery device having an electronic circuit system ➤ Subscribe
8,021,344 Medicament delivery device configured to produce an audible output ➤ Subscribe
7,416,540 Devices systems and methods for medicament delivery ➤ Subscribe
8,544,645 Devices, systems and methods for medicament delivery ➤ Subscribe
8,926,594 Devices, systems and methods for medicament delivery ➤ Subscribe
9,022,980 Medical injector simulation device ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,920,377

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004325202 ➤ Subscribe
Australia 2006210865 ➤ Subscribe
Australia 2007245139 ➤ Subscribe
Australia 2009200841 ➤ Subscribe
Australia 2009246525 ➤ Subscribe
Australia 2012201481 ➤ Subscribe
Australia 2015264857 ➤ Subscribe
Canada 2586525 ➤ Subscribe
Canada 2594627 ➤ Subscribe
Canada 2644547 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Baxter
Citi
QuintilesIMS
Deloitte
Healthtrust
Daiichi Sankyo
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot